Tag: <span>survival</span>

Home / survival
Post

Bacteria in the mouth linked to pulmonary fibrosis survival

by University of Michigan Credit: CC0 Public DomainBacteria in the mouth may play a role in survival from idiopathic pulmonary fibrosis (IPF), finds a new study led by researchers from the University of Michigan and the University of Virginia. The findings come from a larger analysis of the role of the lung microbiome and IPF. Working...

New artificial intelligence offers hope for liver cancer patients with less than 13 percent chance of survival
Post

New artificial intelligence offers hope for liver cancer patients with less than 13 percent chance of survival

by  Queen Mary, University of London Figure S1A. Principal Component Analysis (PCA) of cell line phosphoproteomic data. PCA demonstrates distribution of data according to cell line (intra-hepatic cholangiocarcinoma (CCA) (HuH-28, KKU-213, HuCCT1, OZ), extra-hepatic CCA (CCC-5, TFK-1, EGI-1), gallbladder cancer (TGBC24TKB, TGBC1TKB), benign biliary (MMNK-1) and benign epithelial (MCF-10A). Credit: DOI: 10.1158/0008-5472.CAN-21-0955 Researchers at King’s College...

Continuous dosing improves progression-free survival for melanoma patients with common mutations
Post

Continuous dosing improves progression-free survival for melanoma patients with common mutations

by SWOG A first-of-its-kind randomized clinical trial offers strong and perhaps surprising evidence that a combination of two targeted melanoma drugs when given continuously keeps patients’ cancer from growing or spreading longer when compared with intermittent treatment, according to study results to be presented at the 2020 virtual annual meeting of the American Association for...

COVID-19: Stem Cell Therapy Shows 83% Survival of Coronavirus Patients, Study Found
Post

COVID-19: Stem Cell Therapy Shows 83% Survival of Coronavirus Patients, Study Found

By Tiziana Celine Tech Times Doctors are hoping stem cell therapy may be a weapon in the fight against coronavirus. Regenerative medicine employer Mesoblast introduced a 300-person trial on Friday, Apr. 24, to decide whether or not stem cell treatments will work in COVID-19 patients tormented by severe lung inflammation. The treatments had been intravenous...

Low vitamin D may reduce survival for some with multiple myeloma
Post

Low vitamin D may reduce survival for some with multiple myeloma

Vitamin D deficiency is associated with reduced overall survival for patients with multiple myeloma (MM), with a differential effect across race, according to a study published online April 21 in Blood Advances. Sarvari V. Yellapragada, M.D., from Michael E. DeBakey VA Medical Center in Houston, and colleagues examined the differential impact of vitamin D deficiency...

Post

Learning to stop cancer at its roots

BAYLOR COLLEGE OF MEDICINE Why do some cancers come back? Sometimes, a treatment can effectively eliminate cancer cells to undetectable levels, but, if the treatment stops, cancer may return. This is the case of chronic myeloid leukemia treated with drugs known as tyrosine kinase inhibitors. These drugs have dramatically improved clinical outcomes and generated unprecedented rates of complete responses...

Post

Study provides new insights for ways to use cell metabolism to treat cancer

UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER CINCINNATI–Researchers at the University of Cincinnati (UC) College of Medicine have discovered that cell metabolism plays an important role in the ability of cells to start a survival program called autophagy, an unwanted side effect of some anti-cancer drugs that helps some tumor cells dodge treatment and eventually regrow into...

Post

Researchers discover first treatment to improve survival in rare heart condition

EUROPEAN SOCIETY OF CARDIOLOGY Munich, Germany – 27 Aug 2018: Tafamidis is the first treatment to improve survival and reduce hospitalisations in a rare heart condition called transthyretin amyloid cardiomyopathy, according to late breaking research presented today in a Hot Line Session at ESC Congress 20181 and published in the New England Journal of Medicine. Professor Claudio Rapezzi, principal...